» Articles » PMID: 36882008

Integrative Analysis of Multi-omics and Imaging Data with Incorporation of Biological Information Via Structural Bayesian Factor Analysis

Overview
Journal Brief Bioinform
Specialty Biology
Date 2023 Mar 7
PMID 36882008
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: With the rapid development of modern technologies, massive data are available for the systematic study of Alzheimer's disease (AD). Though many existing AD studies mainly focus on single-modality omics data, multi-omics datasets can provide a more comprehensive understanding of AD. To bridge this gap, we proposed a novel structural Bayesian factor analysis framework (SBFA) to extract the information shared by multi-omics data through the aggregation of genotyping data, gene expression data, neuroimaging phenotypes and prior biological network knowledge. Our approach can extract common information shared by different modalities and encourage biologically related features to be selected, guiding future AD research in a biologically meaningful way.

Method: Our SBFA model decomposes the mean parameters of the data into a sparse factor loading matrix and a factor matrix, where the factor matrix represents the common information extracted from multi-omics and imaging data. Our framework is designed to incorporate prior biological network information. Our simulation study demonstrated that our proposed SBFA framework could achieve the best performance compared with the other state-of-the-art factor-analysis-based integrative analysis methods.

Results: We apply our proposed SBFA model together with several state-of-the-art factor analysis models to extract the latent common information from genotyping, gene expression and brain imaging data simultaneously from the ADNI biobank database. The latent information is then used to predict the functional activities questionnaire score, an important measurement for diagnosis of AD quantifying subjects' abilities in daily life. Our SBFA model shows the best prediction performance compared with the other factor analysis models.

Availability: Code are publicly available at https://github.com/JingxuanBao/SBFA.

Contact: qlong@upenn.edu.

Citing Articles

WIMOAD: Weighted Integration of Multi-Omics data for Alzheimer's Disease (AD) Diagnosis.

Xiao H, Wang J, Wan S bioRxiv. 2024; .

PMID: 39386613 PMC: 11463407. DOI: 10.1101/2024.09.25.614862.


Employing Informatics Strategies in Alzheimer's Disease Research: A Review from Genetics, Multiomics, and Biomarkers to Clinical Outcomes.

Bao J, Lee B, Wen J, Kim M, Mu S, Yang S Annu Rev Biomed Data Sci. 2024; 7(1):391-418.

PMID: 38848574 PMC: 11525791. DOI: 10.1146/annurev-biodatasci-102423-121021.


Knowledge-guided learning methods for integrative analysis of multi-omics data.

Li W, Ballard J, Zhao Y, Long Q Comput Struct Biotechnol J. 2024; 23:1945-1950.

PMID: 38736693 PMC: 11087912. DOI: 10.1016/j.csbj.2024.04.053.


Preference matrix guided sparse canonical correlation analysis for mining brain imaging genetic associations in Alzheimer's disease.

Sha J, Bao J, Liu K, Yang S, Wen Z, Wen J Methods. 2023; 218:27-38.

PMID: 37507059 PMC: 10528049. DOI: 10.1016/j.ymeth.2023.07.007.

References
1.
Murray M, Graff-Radford N, Ross O, Petersen R, Duara R, Dickson D . Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011; 10(9):785-96. PMC: 3175379. DOI: 10.1016/S1474-4422(11)70156-9. View

2.
Lin D, Cao H, Calhoun V, Wang Y . Sparse models for correlative and integrative analysis of imaging and genetic data. J Neurosci Methods. 2014; 237:69-78. PMC: 4194220. DOI: 10.1016/j.jneumeth.2014.09.001. View

3.
Kim M, Bao J, Liu K, Park B, Park H, Baik J . A structural enriched functional network: An application to predict brain cognitive performance. Med Image Anal. 2021; 71:102026. PMC: 8184595. DOI: 10.1016/j.media.2021.102026. View

4.
Weiner M, Veitch D, Aisen P, Beckett L, Cairns N, Green R . Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimers Dement. 2017; 13(4):e1-e85. PMC: 6818723. DOI: 10.1016/j.jalz.2016.11.007. View

5.
Wong A, Krishnan A, Yao V, Tadych A, Troyanskaya O . IMP 2.0: a multi-species functional genomics portal for integration, visualization and prediction of protein functions and networks. Nucleic Acids Res. 2015; 43(W1):W128-33. PMC: 4489318. DOI: 10.1093/nar/gkv486. View